Full Text View
Tabular View
Study Results
Related Studies
Pazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell Carcinoma (COMPARZ)
This study is ongoing, but not recruiting participants.
Study NCT00720941   Information provided by GlaxoSmithKline

First Received on July 22, 2008.   Last Updated on June 19, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
More general drug interventions related to this trial
Sponsors listed in this trial